H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 116 Citations 62,680 322 World Ranking 318 National Ranking 209
Medicine D-index 106 Citations 47,372 319 World Ranking 2805 National Ranking 1624

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

Cell biology, TSC1, TSC2, Genetics and Tuberous sclerosis are his primary areas of study. His work is dedicated to discovering how Cell biology, Molecular biology are connected with Cell growth and other disciplines. His TSC1 study combines topics in areas such as mTORC1, Heterozygote advantage, Neuroscience and Sirolimus.

As a member of one scientific family, David J. Kwiatkowski mostly works in the field of TSC2, focusing on Cancer research and, on occasion, Protein kinase B, CDKN2A, Chromophobe cell, Carcinoma and Germline mutation. His Tuberous sclerosis research also works with subjects such as

  • Tuberous sclerosis protein, which have a strong connection to Genotype,
  • Hamartoma together with Endocrinology. His research investigates the connection between Gene and topics such as Adenocarcinoma that intersect with issues in KRAS.

His most cited work include:

  • Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network (2762 citations)
  • Comprehensive genomic characterization of squamous cell lung cancers (2590 citations)
  • Comprehensive molecular characterization of urothelial bladder carcinoma (1756 citations)

What are the main themes of his work throughout his whole career to date?

David J. Kwiatkowski focuses on Cancer research, Tuberous sclerosis, Genetics, TSC1 and Internal medicine. His work focuses on many connections between Cancer research and other disciplines, such as PI3K/AKT/mTOR pathway, that overlap with his field of interest in Sirolimus and Protein kinase B. David J. Kwiatkowski works mostly in the field of TSC1, limiting it down to topics relating to TSC2 and, in certain cases, Germline mutation and Tumor suppressor gene, as a part of the same area of interest.

The various areas that David J. Kwiatkowski examines in his Internal medicine study include Endocrinology and Oncology. His work in Gene addresses subjects such as Molecular biology, which are connected to disciplines such as Cell biology and Exon. His Lung cancer study combines topics from a wide range of disciplines, such as KRAS and Adenocarcinoma.

He most often published in these fields:

  • Cancer research (30.18%)
  • Tuberous sclerosis (26.14%)
  • Genetics (25.79%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (30.18%)
  • Internal medicine (22.98%)
  • Oncology (14.56%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Cancer research, Internal medicine, Oncology, Tuberous sclerosis and TSC1. His work deals with themes such as Cell growth, mTORC1, PI3K/AKT/mTOR pathway, Mutation and Renal cell carcinoma, which intersect with Cancer research. His research in Internal medicine intersects with topics in Somatic cell, ARID1A and Medical genetics.

His Oncology research is mostly focused on the topic Lung cancer. His Tuberous sclerosis research is under the purview of Pathology. His TSC1 research is multidisciplinary, incorporating perspectives in Subependymal zone, Kidney Angiomyolipoma, Angiomyolipoma, Microphthalmia-associated transcription factor and TSC2.

Between 2017 and 2021, his most popular works were:

  • The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (293 citations)
  • Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology (289 citations)
  • Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology (227 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

David J. Kwiatkowski mainly investigates Oncology, Internal medicine, Cancer research, Tuberous sclerosis and Lung cancer. His work in the fields of Internal medicine, such as Urothelial carcinoma, intersects with other areas such as Hepatocyte Growth Factor Receptor. The Cancer research study combines topics in areas such as Mutation, Cancer, Renal cell carcinoma and Chromophobe Renal Cell Carcinoma.

His research integrates issues of Autism, TSC2, TSC1 and Epilepsy in his study of Tuberous sclerosis. TSC2 is a primary field of his research addressed under PI3K/AKT/mTOR pathway. David J. Kwiatkowski has researched Lung cancer in several fields, including Fluorescence in situ hybridization, Guideline, Molecular pathology and KRAS.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger.
Nature (2014)

3773 Citations

Comprehensive molecular characterization of urothelial bladder carcinoma

John N Weinstein;Rehan Akbani;Bradley McIntosh Broom;Wenyi Wang.
Nature (2014)

2525 Citations

Comprehensive genomic characterization of squamous cell lung cancers

Peter S. Hammerman;Doug Voet;Michael S. Lawrence;Douglas Voet.
Nature (2012)

2278 Citations

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

Marjon van Slegtenhorst;Ronald de Hoogt;Caroline Hermans;Mark Nellist.
Science (1997)

1650 Citations

Caspase-3-Generated Fragment of Gelsolin: Effector of Morphological Change in Apoptosis

Srinivas Kothakota;Toshifumi Azuma;Christoph Reinhard;Anke Klippel.
Science (1997)

1642 Citations

Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing

Marcin Imielinski;Alice H. Berger;Alice H. Berger;Peter S. Hammerman;Peter S. Hammerman;Bryan Hernandez.
Cell (2012)

1556 Citations

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally.
Cell (2014)

1464 Citations

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Neal I. Lindeman;Philip T. Cagle;Mary Beth Beasley;Dhananjay Arun Chitale.
Journal of Thoracic Oncology (2013)

1400 Citations

Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

Mark G. Kris;Bruce E. Johnson;Lynne D. Berry;David J. Kwiatkowski.
JAMA (2014)

1262 Citations

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

A. Gordon Robertson;Jaegil Kim;Hikmat Al-Ahmadie;Joaquim Bellmunt.
Cell (2017)

1068 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David J. Kwiatkowski

Gad Getz

Gad Getz

Broad Institute

Publications: 127

Matthew Meyerson

Matthew Meyerson

Harvard University

Publications: 120

Pasi A. Jänne

Pasi A. Jänne

Harvard University

Publications: 102

Ming-Sound Tsao

Ming-Sound Tsao

Princess Margaret Cancer Centre

Publications: 101

Paul A. Janmey

Paul A. Janmey

University of Pennsylvania

Publications: 98

Kwok-Kin Wong

Kwok-Kin Wong

New York University

Publications: 96

Ignacio I. Wistuba

Ignacio I. Wistuba

The University of Texas MD Anderson Cancer Center

Publications: 94

John V. Heymach

John V. Heymach

The University of Texas MD Anderson Cancer Center

Publications: 81

Liang Cheng

Liang Cheng

Indiana University

Publications: 80

Jonathan E. Rosenberg

Jonathan E. Rosenberg

Memorial Sloan Kettering Cancer Center

Publications: 80

Eliezer M. Van Allen

Eliezer M. Van Allen

Harvard University

Publications: 80

Edwin K. Silverman

Edwin K. Silverman

Brigham and Women's Hospital

Publications: 80

Joel Moss

Joel Moss

National Institutes of Health

Publications: 78

Thomas P. Stossel

Thomas P. Stossel

Brigham and Women's Hospital

Publications: 77

Gordon B. Mills

Gordon B. Mills

Oregon Health & Science University

Publications: 75

Yi Zheng

Yi Zheng

Cincinnati Children's Hospital Medical Center

Publications: 73

Something went wrong. Please try again later.